SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $201 | -65.6% | 7,287 | -55.6% | 0.02% | -76.7% |
Q4 2022 | $585 | -99.8% | 16,394 | +63.6% | 0.07% | +69.8% |
Q1 2022 | $324,000 | -68.2% | 10,023 | -76.6% | 0.04% | -63.9% |
Q4 2019 | $1,018,000 | +274.3% | 42,925 | +334.2% | 0.12% | +221.6% |
Q3 2019 | $272,000 | -5.9% | 9,886 | +13.6% | 0.04% | +12.1% |
Q4 2018 | $289,000 | -86.5% | 8,700 | -75.7% | 0.03% | -68.9% |
Q2 2018 | $2,141,000 | -24.8% | 35,777 | -42.4% | 0.11% | -29.8% |
Q1 2018 | $2,846,000 | +6.4% | 62,134 | -7.4% | 0.15% | -7.4% |
Q4 2017 | $2,675,000 | +62.6% | 67,134 | +63.2% | 0.16% | +45.5% |
Q3 2017 | $1,645,000 | -64.9% | 41,134 | -62.2% | 0.11% | -63.4% |
Q2 2017 | $4,686,000 | +8.6% | 108,734 | -21.1% | 0.31% | +31.9% |
Q1 2017 | $4,314,000 | +34.7% | 137,834 | +8.7% | 0.23% | +21.5% |
Q4 2016 | $3,202,000 | +2.2% | 126,829 | +0.1% | 0.19% | +13.7% |
Q3 2016 | $3,134,000 | -26.9% | 126,734 | -39.8% | 0.17% | -29.1% |
Q2 2016 | $4,286,000 | +11.5% | 210,429 | -16.5% | 0.24% | -3.3% |
Q1 2016 | $3,845,000 | +30.3% | 252,109 | +14.8% | 0.24% | +70.1% |
Q4 2015 | $2,951,000 | -1.9% | 219,572 | +2.4% | 0.14% | -2.7% |
Q3 2015 | $3,008,000 | +48.3% | 214,379 | +79.5% | 0.15% | +89.7% |
Q2 2015 | $2,028,000 | – | 119,406 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
S&T BANK/PA | 223,775 | $8,107 | 1.46% |
Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |